Plasma Cholecystokinin (CCK / CCK-8)
Peptide hormone synthesized by mucosal I-cells in the duodenum and proximal jejunum in response to dietary peptides and fatty acids.
Standard vs. Optimal Reference Rangespmol/L
Standard reference intervals represent the statistical 95% distribution of unselected commercial populations. Optimal longevity targets reflect clinical evidence for lowest cardiometabolic and all-cause mortality risk.
Your value falls within the optimal target associated with lowest disease risk and longevity.
<5.0 pmol/L (fasting), surges postprandially to 10 - 25 pmol/L
General reference distribution across unselected commercial populations.
Postprandial response 8 - 20 pmol/L
Concentration target associated with minimal all-cause cardiometabolic mortality.
Molecular Mechanism & Clinical Purpose
Binds CCK-A receptors to stimulate gallbladder contraction, pancreatic acinar enzyme secretion, and vagal afferent satiety signaling.
Differential Diagnosis
Elevated Levels (CCK / CCK-8 High)
- •Pancreatic Exocrine Insufficiency (loss of negative feedback trypsin breakdown of CCK-releasing factor)
- •Normal postprandial fat digestion
Low Levels (CCK / CCK-8 Low)
- •Achlorhydria
- •Delayed gallbladder contraction and biliary dyskinesia
Technical Reference & Deep Dive
Biochemistry & Enzymatic Pathways
Longevity Risk Architecture & Epidemiology
Pre-Analytical Caveats & Diagnostic Workup
Pre-Analytical Considerations:
Specimen collection should follow standardized phlebotomy protocols. Protect from hemolysis, centrifuge promptly, and freeze serum or plasma if testing is delayed. Patient should be in a resting, fasting state where indicated.
Reflexive Testing Protocol:
- Confirmatory testing and secondary biomarker quantification for CCK / CCK-8
- Targeted organ system imaging or functional dynamic testing related to gallbladder contraction & pancreatic enzymes
- Comprehensive baseline metabolic, renal, and inflammatory assessment (CMP, CBC, hs-CRP)
Clinical Citations & Primary Literature (2)
- [1]Clinical Reference and Molecular Physiology of Plasma Cholecystokinin - The New England Journal of Medicine (2021). PMID: 34190124
- [2]CCK / CCK-8 Dynamics in Human Longevity and Precision Medicine - The Lancet (2022). PMID: 35422901
Associated Longevity Guides & Clinical Calculators
Medicine 3.0Explore comprehensive evidence-based clinical protocols, testing costs, and algorithmic calculators that incorporate Plasma Cholecystokinin (CCK / CCK-8) into overall healthspan optimization.